<DOC>
	<DOC>NCT01304433</DOC>
	<brief_summary>The study is primarily aimed to collect further data on the safety of the investigational product in a large patient population when used in routine clinical practice in the Asian-Pacific region.</brief_summary>
	<brief_title>Safety Profile of Hydroxyethyl Starch</brief_title>
	<detailed_description />
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Inclusion: patients with ASA risk score â‰¤ III, nonemergency patients, i.e. elective surgery Exclusion: contraindications as listed for HES 130/0.42</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>